| Literature DB >> 34250093 |
Yalin Zhao1, Meihua Li1, Yanxia Yang1, Tao Wu1, Qingyuan Huang1, Qinghua Wu1, Chaofeng Ren1.
Abstract
OBJECTIVES: Chronic obstructive pulmonary disease (COPD) is characterized by lung inflammation and remodeling. Macrophage polarization is associated with inflammation and tissue remodeling, as well as immunity. Therefore, this study attempts to investigate the diagnostic value and regulatory mechanism of macrophage polarization-related genes for COPD by bioinformatics analysis and to provide a new theoretical basis for experimental research.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34250093 PMCID: PMC8238569 DOI: 10.1155/2021/9921012
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Construction weighted gene coexpression network and identification of modules related to the markers of macrophage polarization. (a) Determination the optimal soft threshold to conform to the scale-free distribution. (b) Dendrogram of genes clustered based on the highly correlated eigengenes (correlation above 0.6).
Figure 2Identification of genes associated with COPD and macrophage polarization. (a) Volcano plot showed the DEGs between COPD samples and normal samples. (b) Overlapping genes between DEGs and macrophage polarization-related genes. (c) Heatmap exhibited the differential expression of the candidate genes between COPD samples and normal samples.
The results of GO functional annotation and KEGG pathways for the 25 candidate genes.
| ID | Biological process | KEGG pathway |
|---|---|---|
| CBR3 | GO:0042376 ~ phylloquinone catabolic process, GO:0050890 ~ cognition, GO:0055114 ~ oxidation-reduction process | hsa00590: arachidonic acid metabolism, hsa00980: metabolism of xenobiotics by cytochrome P450, hsa01100: metabolic pathways |
| FZD6 | GO:0001736 ~ establishment of planar polarity, GO:0001843 ~ neural tube closure, GO:0001942 ~ hair follicle development, GO:0007186 ~ G-protein coupled receptor signaling pathway, GO:0007223 ~ Wnt signaling pathway, calcium modulating pathway, GO:0007275 ~ multicellular organism development, GO:0030168 ~ platelet activation, GO:0033278 ~ cell proliferation in midbrain, GO:0035567 ~ non-canonical Wnt signaling pathway, GO:0035880 ~ embryonic nail plate morphogenesis, GO:0042472 ~ inner ear morphogenesis, GO:0043433 ~ negative regulation of sequence-specific DNA binding transcription factor activity, GO:0060071 ~ Wnt signaling pathway, planar cell polarity pathway, GO:0090090 ~ negative regulation of canonical Wnt signaling pathway, GO:1904693 ~ midbrain morphogenesis | hsa04310: Wnt signaling pathway, hsa04390: Hippo signaling pathway, hsa04550: signaling pathways regulating pluripotency of stem cells, hsa04916: melanogenesis, hsa05166:HTLV-I infection, hsa05200: pathways in cancer, hsa05205: proteoglycans in cancer, hsa05217: basal cell carcinoma |
| NEFL | GO:0000165 ~ MAPK cascade, GO:0000226 ~ microtubule cytoskeleton organization, GO:0008089 ~ anterograde axonal transport, GO:0008090 ~ retrograde axonal transport, GO:0009636 ~ response to toxic substance, GO:0014012 ~ peripheral nervous system axon regeneration, GO:0019896 ~ axonal transport of mitochondrion, GO:0021510 ~ spinal cord development, GO:0021766 ~ hippocampus development, GO:0021987 ~ cerebral cortex development, GO:0031133 ~ regulation of axon diameter, GO:0033693 ~ neurofilament bundle assembly, GO:0040011 ~ locomotion, GO:0043434 ~ response to peptide hormone, GO:0043524 ~ negative regulation of neuron apoptotic process, GO:0043547 ~ positive regulation of GTPase activity, GO:0045105 ~ intermediate filament polymerization or depolymerization, GO:0045109 ~ intermediate filament organization, GO:0048812 ~ neuron projection morphogenesis, GO:0050772 ~ positive regulation of axonogenesis, GO:0050885 ~ neuromuscular process controlling balance, GO:0051258 ~ protein polymerization, GO:0051412 ~ response to corticosterone, GO:0061564 ~ axon development, GO:1903935 ~ response to sodium arsenite, GO:1903937 ~ response to acrylamide | hsa05014: amyotrophic lateral sclerosis (ALS), |
| ZNF676 | GO:0006351 ~ transcription, DNA-templated, GO:0006355 ~ regulation of transcription, DNA-templated | |
| PROX2 | GO:0000122 ~ negative regulation of transcription from RNA polymerase II promoter, GO:0006351 ~ transcription, DNA-templated, GO:0030182 ~ neuron differentiation, GO:0045944 ~ positive regulation of transcription from RNA polymerase II promoter, GO:0055007 ~ cardiac muscle cell differentiation | |
| HMMR | GO:0000086 ~ G2/M transition of mitotic cell cycle, GO:0030214 ~ hyaluronan catabolic process | hsa04512: ECM-receptor interaction |
| GEM | GO:0006955 ~ immune response, GO:0007067 ~ mitotic nuclear division, GO:0007165 ~ signal transduction, GO:0007166 ~ cell surface receptor signaling pathway, GO:0007264 ~ small GTPase mediated signal transduction, GO:0051276 ~ chromosome organization, GO:0051310 ~ metaphase plate congression | |
| HESX1 | GO:0006351 ~ transcription, DNA-templated, GO:0007420 ~ brain development,GO:0030916 ~ otic vesicle formation, GO:0043584 ~ nose development, GO:0045892 ~ negative regulation of transcription, DNA-templated, GO:0048853 ~ forebrain morphogenesis, | hsa04550: signaling pathways regulating pluripotency of stem cells |
| PRDM6 | GO:0006351 ~ transcription, DNA-templated, GO:0022008 ~ neurogenesis, GO:0034968 ~ histone lysine methylation, GO:0045892 ~ negative regulation of transcription, DNA-templated, GO:0051151 ~ negative regulation of smooth muscle cell differentiation | |
|
| ||
| S100B | GO:0007409 ~ axonogenesis, GO:0007417 ~ central nervous system development, GO:0007611 ~ learning or memory, GO:0007613 ~ memory, GO:0008283 ~ cell proliferation, GO:0008284 ~ positive regulation of cell proliferation, GO:0008360 ~ regulation of cell shape, GO:0043065 ~ positive regulation of apoptotic process, GO:0043123 ~ positive regulation of I-kappaB kinase/NF-kappaB signaling, GO:0045087 ~ innate immune response, GO:0048168 ~ regulation of neuronal synaptic plasticity, GO:0048708 ~ astrocyte differentiation, GO:0051384 ~ response to glucocorticoid, GO:0051597 ~ response to methylmercury, GO:0060291 ~ long-term synaptic potentiation, GO:0071456 ~ cellular response to hypoxia, GO:2001015 ~ negative regulation of skeletal muscle cell differentiation | |
| CENPS | GO:0000712 ~ resolution of meiotic recombination intermediates, GO:0006281 ~ DNA repair, GO:0006312 ~ mitotic recombination, GO:0006974 ~ cellular response to DNA damage stimulus, GO:0007062 ~ sister chromatid cohesion, GO:0007067 ~ mitotic nuclear division, GO:0031297 ~ replication fork processing, GO:0031398 ~ positive regulation of protein ubiquitination, GO:0034080 ~ CENP-A containing nucleosome assembly, GO:0036297 ~ interstrand cross-link repair, GO:0051301 ~ cell division, GO:0051382 ~ kinetochore assembly | hsa03460: Fanconi anemia pathway |
|
| ||
| GZMA | GO:0006915 ~ apoptotic process, GO:0006955 ~ immune response, GO:0019835 ~ cytolysis, GO:0032078 ~ negative regulation of endodeoxyribonuclease activity, GO:0043065 ~ positive regulation of apoptotic process, GO:0043392 ~ negative regulation of DNA binding, GO:0051354 ~ negative regulation of oxidoreductase activity, GO:0051603 ~ proteolysis involved in cellular protein catabolic process | hsa04080: neuroactive ligand-receptor interaction |
| NEBL | GO:0071691 ~ cardiac muscle thin filament assembly | |
| RNF43 | GO:0016055 ~ Wnt signaling pathway, GO:0016567 ~ protein ubiquitination, GO:0030178 ~ negative regulation of Wnt signaling pathway, GO:0038018 ~ Wnt receptor catabolic process, GO:0042787 ~ protein ubiquitination involved in ubiquitin-dependent protein catabolic process, GO:0072089 ~ stem cell proliferation, | |
| SPINK2 | GO:0002176 ~ male germ cell proliferation, GO:0007286 ~ spermatid development, GO:0009566 ~ fertilization, GO:0043065 ~ positive regulation of apoptotic process, GO:0060046 ~ regulation of acrosome reaction, GO:0072520 ~ seminiferous tubule development, GO:1900004 ~ negative regulation of serine-type endopeptidase activity | |
| UTS2 | GO:0001666 ~ response to hypoxia, GO:0003105 ~ negative regulation of glomerular filtration, GO:0006936 ~ muscle contraction, GO:0007204 ~ positive regulation of cytosolic calcium ion concentration, GO:0007268 ~ chemical synaptic transmission, GO:0008217 ~ regulation of blood pressure, GO:0010459 ~ negative regulation of heart rate, GO:0010460 ~ positive regulation of heart rate, GO:0010763 ~ positive regulation of fibroblast migration, GO:0010841 ~ positive regulation of circadian sleep/wake cycle, wakefulness, GO:0032224 ~ positive regulation of synaptic transmission, cholinergic, GO:0032967 ~ positive regulation of collagen biosynthetic process, GO:0033574 ~ response to testosterone, GO:0035811 ~ negative regulation of urine volume, GO:0035814 ~ negative regulation of renal sodium excretion, GO:0042312 ~ regulation of vasodilation, GO:0042493 ~ response to drug, GO:0045597 ~ positive regulation of cell differentiation, GO:0045766 ~ positive regulation of angiogenesis,GO:0045776 ~ negative regulation of blood pressure, GO:0045777 ~ positive regulation of blood pressure, GO:0045909 ~ positive regulation of vasodilation, GO:0046005 ~ positive regulation of circadian sleep/wake cycle, REM sleep,GO:0046676 ~ negative regulation of insulin secretion,GO:0048146 ~ positive regulation of fibroblast proliferation, |
Figure 3Correlation between candidate biomarkers and immune-infiltrated cells. (a) Box plot displayed the immune cell infiltration levels between COPD samples and normal samples. (b) Bubble plots showed the correlation between candidate biomarkers and immune-infiltrated cells. (c) Heatmap exhibited the correlation between candidate biomarkers and the marker genes of B cells.
Figure 4Association between candidate biomarkers and B cell receptor signaling pathway. (a) Regulation network of the B cell receptor signaling pathway. (b) Heatmap exhibited the correlation between candidate biomarkers and the genes in the B cell receptor signaling pathway.
Figure 5Construction of PPI network. (a) PPI network for candidate biomarkers and other DEGs. (b) PPI network for GEM and other DEGs.
Figure 6Investigation of the accuracy of the candidate biomarkers for distinguishing the COPD samples from normal samples. (a) Construction of the LASSO model based on 3 candidate biomarkers: (A) image showed the log (lambda) value of the 3 candidate biomarkers and (B) image showed the distribution of the log (lambda) value in the LASSO model. (c) ROC curve for the LASSO model. (d) ROC curve for the GEM.